Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy
โ Scribed by Lennox Jeffers; Naga Chalasani; Luis Balart; Nikolaos Pyrsopoulos; Elisabeth Erhardtsen
- Book ID
- 119756633
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 114 KB
- Volume
- 123
- Category
- Article
- ISSN
- 0016-5085
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Orthotopic liver transplantation (OLT) can be associated with excessive blood loss. As a result, there may be increased risk of adverse outcomes. Activated recombinant factor VII (rFVIIa) has demonstrated the ability to improve hemostasis in a variety of disorders; however, there has been a limited
## Patients undergoing orthotopic liver transplantation (OLT) have excessive blood loss during surgery that requires blood transfusions, leading to increased postoperative morbidity and mortality. We studied the efficacy and safety of activated recombinant factor VII (rFVIIa) in reducing transfusio